• Sun Pharma’s Mohali plant on FDA radar financialexpress
    September 13, 2018
    Recently, the USFDA had issued Form 483 with six observations related to deficient procedures after an inspection of the company’s Halol facility in Gujarat
PharmaSources Customer Service